@danielaletaha.bsky.social
Rheumatologist, Medical University Vienna - Past-President of EULAR
At KinderUni 2025, our division of Rheumatology @meduniwien.ac.at explored the fascinating world of autoimmunity with Vienna’s youngest scientists. Huge thanks to our amazing team for inspiring future researchers! 👉 kinderuni-anmeldung.at/event.php?ev...
01.08.2025 07:39 — 👍 3 🔁 0 💬 0 📌 0
Idiopathic #inflammatorymyopathies are rare #autoimmunediseases in which the #immunesystem attacks the body's own #musclecells.
A team from #MedUniVienna has systematically described the safety and efficacy of targeted #immunotherapy in refractory idiopathic inflammatory #myopathies. ⬇️
New review in Joint Bone Spine co-authored by our team highlights ultrasound's expanding role from joints to organ involvement in rheumatic diseases. Read more 👉 www.sciencedirect.com/science/arti...
07.07.2025 09:12 — 👍 0 🔁 0 💬 0 📌 0
Great meeting in Stockholm with the @autopix.bsky.social team! Thanks @collectiveminds.bsky.social for hosting. We're advancing AI tools to improve rheumatic care - excited for what’s ahead!
30.06.2025 10:18 — 👍 1 🔁 0 💬 0 📌 0Check out the interview I made within the frame of #EULAR2025 with the talented EMEUNET Newsletter Sub-Committee members Anastasia Madenidou and Victoria Konzett 👇
emeunews.org/2025/06/01/t...
Check out my interview, masterfully led by Valentina Pucino after the plenary session of #EULAR2025 👇
www.youtube.com/watch?v=d6hi...
Proud to showcase the @squeezeproject.bsky.social at #EULAR2025! Visit booth O9 (near Hall 8.1, NPO area) to learn how we’re advancing precision medicine in RA to get the right treatment to the right patient.
12.06.2025 08:49 — 👍 3 🔁 0 💬 0 📌 0Proud of our @autopix.bsky.social at #EULAR2025! Visit us at booth O8 (near Hall 8.1, NPO area) to learn how we’re using AI to advance rheumatic image analysis for better patient care.
12.06.2025 08:48 — 👍 5 🔁 0 💬 0 📌 0
And that’s the start of what it’s going to be a very exciting @eular.org Congress!
Open ceremony with @danielaletaha.bsky.social
#EULAR2025
🎙️ Mark the first of many SQUEEZE talks at #EULAR2025: "Add-on vs. Replacement csDMARDs post-MTX. A European analysis on csDMARD Treatment Choices." Presented by Nils Steinz from Leiden University Medical Center (LUMC) on June 12, at 10:50 am at room A2. #RA #DMARD #PrecisionMedicine
02.06.2025 05:36 — 👍 7 🔁 3 💬 0 📌 0🟣 Today, on International Day of Action for Women’s Health, we reaffirm: women’s health is central to rheumatology - from research to care. Let’s keep pushing forward.
may28.org
#WomensHealthMatters #Rheumatology #AutoimmuneDiseases #HealthEquity
I was interviewed by my team to share why EULAR 2025 in Barcelona will be exciting—and why you shouldn't miss it!📺 www.youtube.com/watch?v=rvf5... #EULAR2025
26.05.2025 07:51 — 👍 1 🔁 0 💬 0 📌 0Can we prevent rheumatoid arthritis before it starts? Research on preclinical RA suggests early intervention could halt or delay the disease. Could prevention be the future of RA care? Read our latest editorial! 🔗 doi.org/10.1016/j.jb...
22.05.2025 11:12 — 👍 0 🔁 0 💬 0 📌 0
Last week was our first meetup with the Patient Research Partners involved in our IHI-funded AutoPiX project!
We’re using AI to dig deeper into imaging data in rheumatic diseases care. Big thanks to everyone bringing their voice to the table! 💬🤝
#PatientInvolvement #Rheumatology #AI
Proud to share that Josef S. Smolen has been named a 2024 Highly Ranked Scholar – Lifetime by ScholarGPS, placing him in the top 0.05% worldwide in medicine (tinyurl.com/3kwv6wem). A true inspiration and mentor — congratulations, Josef, particularly from all your academic offspring! 👏
24.04.2025 08:30 — 👍 2 🔁 0 💬 0 📌 0
🎧 New on the Digital Rheumatology Network podcast: Our very own Paul Studenic shares his insights from ACR & EULAR, tech trends, and patient empowerment:
🔗 tinyurl.com/3j8ha8ch
#DigitalRheumatology #DigitalHealth #EULAR #ACR #FutureOfCare
🎉 Halfway there! Our @SQUEEZE project hits its 2.5-year mark! We've advanced RA treatment with biomarker research, launched 3 clinical trials, and strengthened patient engagement. Exciting progress ahead as we optimize therapies! Stay tuned: tinyurl.com/47uv45ts
17.04.2025 07:43 — 👍 3 🔁 0 💬 0 📌 0
Josef Smolen and I co-founded Preferrix to improve clinical trial access. Now live as a Meduniwien spin-off, it connects doctors and trial centers, expanding recruitment beyond specialized clinics and for all patients regardless of where they receive care: tinyurl.com/34659wwc
14.04.2025 07:41 — 👍 2 🔁 0 💬 0 📌 0How should we treat undifferentiated arthritis in 2025? Annette van der Helm-van Mil and I challenge existing paradigms a recent viewpoint. UA is not just "early RA"—today’s patients present differently, with milder disease and frequent remission. Time to rethink treatment. doi.org/10.1016/j.ar...
10.04.2025 08:35 — 👍 0 🔁 0 💬 0 📌 0Check out our new reviews on JAK inhibitors in IMIDs:
📌 Efficacy: 102 RCTs, 21 JAK inhibitors, 51 diseases—strong evidence across IMIDs.
📌 Safety: 209 studies analyzed risks like CV events, infections, malignancies.
doi.org/10.1016/j.ar... & doi.org/10.1016/j.ar...
Ich freue mich, mein Interview mit Die ganze WOCHE zu teilen: tinyurl.com/bdzz8ss8 📰
Wie uns künstliche Intelligenz hilft die Behandlung von entzündlichem Gelenksrheuma präziser zu gestalten und wie wir in unserem AutoPiX-Projekt die Auswertung von Bilddaten verbessern: www.autopix-project.eu 🏥🔬
Our Division of Rheumatology hosted its annual General Recess—an inspiring forum for research exchange! This year, we also launched Rheumavation, a 1-minute pitch challenge for innovative ideas.
Congrats to our first-ever winners, Marlene Steiner & Lisabeth Emilius! 👏 #Rheumatology #Innovation
